HOOK1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.535400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.708400E-01
Normal-vs-Stage2
8.604800E-01
Normal-vs-Stage3
3.115600E-01
Normal-vs-Stage4
1.959560E-01
Stage1-vs-Stage2
1.495440E-01
Stage1-vs-Stage3
5.041600E-02
Stage1-vs-Stage4
6.497400E-01
Stage2-vs-Stage3
1.709820E-01
Stage2-vs-Stage4
1.046830E-01
Stage3-vs-Stage4
7.115600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.514200E-01
Normal-vs-AfricanAmerican
2.566800E-01
Normal-vs-Asian
7.125800E-01
Caucasian-vs-AfricanAmerican
9.308000E-02
Caucasian-vs-Asian
9.136300E-02
AfricanAmerican-vs-Asian
7.663700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.542000E-01
Normal-vs-Female
7.404800E-01
Male-vs-Female
8.303200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.319400E-01
Normal-vs-Age(41-60Yrs)
5.976400E-01
Normal-vs-Age(61-80Yrs)
8.203000E-01
Normal-vs-Age(81-100Yrs)
6.735400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.294300E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.987800E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.481770E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.996800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.014580E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.841800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.199400E-01
Normal-vs-Daily Drinker
8.107400E-01
Normal-vs-Weekly Drinker
2.755200E-01
Normal-vs-Occasional Drinker
4.578400E-01
Normal-vs-Social Drinker
7.528400E-01
Non Drinker-vs-Daily Drinker
4.470000E-01
Non Drinker-vs-Weekly Drinker
5.569700E-02
Non Drinker-vs-Occasional Drinker
6.582200E-02
Non Drinker-vs-Social Drinker
4.187600E-01
Daily Drinker-vs-Weekly Drinker
3.426100E-02
Daily Drinker-vs-Occasional Drinker
2.624200E-01
Daily Drinker-vs-Social Drinker
7.968400E-01
Weekly Drinker-vs-Occasional Drinker
4.978800E-03
Weekly Drinker-vs-Social Drinker
7.501600E-02
Occasional Drinker-vs-Social Drinker
4.894800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.383840E-01
Normal-vs-Grade 2
2.822500E-02
Normal-vs-Grade 3
5.762000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.155770E-01
Grade 1-vs-Grade 3
1.848180E-01
Grade 1-vs-Grade 4
1.383840E-01
Grade 2-vs-Grade 3
5.791800E-01
Grade 2-vs-Grade 4
2.822500E-02
Grade 3-vs-Grade 4
5.762000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.293400E-01
Normal-vs-NonDiabetic
7.760600E-01
Diabetic-vs-NonDiabetic
1.324040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.047800E-01
Normal-vs-NoPancreatitis
8.397200E-01
Pancreatitis-vs-NoPancreatitis
5.343600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.935600E-01
Normal-vs-N1
8.272200E-01
N0-vs-N1
2.912000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.361400E-01
Normal-vs-TP53-NonMutant
3.707200E-01
TP53-Mutant-vs-TP53-NonMutant
6.552300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
